BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 26744883)

  • 1. Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
    Giacoppo S; Soundara Rajan T; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4906-19. PubMed ID: 26744883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.
    Giacoppo S; Galuppo M; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Daru; 2015 Oct; 23():48. PubMed ID: 26489494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice.
    Gallily R; Yekhtin Z
    Inflammopharmacology; 2019 Feb; 27(1):167-173. PubMed ID: 30291491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis.
    Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E
    Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.
    González-García C; Torres IM; García-Hernández R; Campos-Ruíz L; Esparragoza LR; Coronado MJ; Grande AG; García-Merino A; Sánchez López AJ
    Exp Neurol; 2017 Dec; 298(Pt A):57-67. PubMed ID: 28867485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice.
    Kozela E; Lev N; Kaushansky N; Eilam R; Rimmerman N; Levy R; Ben-Nun A; Juknat A; Vogel Z
    Br J Pharmacol; 2011 Aug; 163(7):1507-19. PubMed ID: 21449980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors.
    Mecha M; Feliú A; Iñigo PM; Mestre L; Carrillo-Salinas FJ; Guaza C
    Neurobiol Dis; 2013 Nov; 59():141-50. PubMed ID: 23851307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL/6 mice.
    Rahimi A; Faizi M; Talebi F; Noorbakhsh F; Kahrizi F; Naderi N
    Neuroscience; 2015 Apr; 290():279-87. PubMed ID: 25637488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.
    Al-Ghezi ZZ; Miranda K; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2019; 10():1921. PubMed ID: 31497013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome.
    Al-Ghezi ZZ; Busbee PB; Alghetaa H; Nagarkatti PS; Nagarkatti M
    Brain Behav Immun; 2019 Nov; 82():25-35. PubMed ID: 31356922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells.
    Kozela E; Juknat A; Gao F; Kaushansky N; Coppola G; Vogel Z
    J Neuroinflammation; 2016 Jun; 13(1):136. PubMed ID: 27256343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
    Trubiani O; Giacoppo S; Ballerini P; Diomede F; Piattelli A; Bramanti P; Mazzon E
    Stem Cell Res Ther; 2016 Jan; 7():1. PubMed ID: 26729060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Attenuates
    Vitarelli da Silva T; Bernardes D; Oliveira-Lima OC; Fernandes Pinto B; Limborço Filho M; Fraga Faraco CC; Juliano MA; Esteves Arantes RM; A Moreira F; Carvalho-Tavares J
    Cannabis Cannabinoid Res; 2024 Apr; 9(2):537-546. PubMed ID: 36745386
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review.
    Furgiuele A; Cosentino M; Ferrari M; Marino F
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):251-269. PubMed ID: 33492630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis.
    Feliú A; Moreno-Martet M; Mecha M; Carrillo-Salinas FJ; de Lago E; Fernández-Ruiz J; Guaza C
    Br J Pharmacol; 2015 Jul; 172(14):3579-95. PubMed ID: 25857324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
    Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
    Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis.
    Dopkins N; Miranda K; Wilson K; Holloman BL; Nagarkatti P; Nagarkatti M
    J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):15-32. PubMed ID: 34757526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.